Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice
- 1 September 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 295 (3), F772-F779
- https://doi.org/10.1152/ajprenal.00019.2008
Abstract
The objectives of this study were to determine the effects of chronic angiotensin II (ANG II) infusions on ANG II content and angiotensinogen expression in the mouse kidney and the role of the angiotensin II type 1 receptor (AT1R) in mediating these changes. C57BL/6J male mice were subjected to ANG II infusions at doses of 400 or 1,000 ng·kg−1·min−1either alone or with an AT1R blocker (olmesartan; 3 mg·kg−1·day−1) for 12 days. Systolic and mean arterial pressures were determined by tail-cuff plethysmography and radiotelemetry. On day 13, blood and kidneys were collected for ANG II determinations by radioimmunoanalysis and intrarenal angiotensinogen expression studies by quantitative RT-PCR, Western blotting, and immunohistochemistry. ANG II infusions at the low dose elicited progressive increases in systolic blood pressure (135 ± 2.5 mmHg). In contrast, the high dose induced a rapid increase (152 ± 2.5, P < 0.05 vs. controls, 109 ± 2.8). Renal ANG II content was increased by ANG II infusions at the low dose (1,203 ± 253 fmol/g) and the high dose (1,258 ± 173) vs. controls (499 ± 40, P < 0.05). Kidney angiotensinogen mRNA and protein were increased only by the low dose to 1.13 ± 0.02 and 1.26 ± 0.10, respectively, over controls (1.00, P < 0.05). These effects were not observed in mice infused at the high dose and those receiving olmesartan. The results indicate that chronic ANG II infusions augment mouse intrarenal ANG II content with AT1R-dependent uptake occurring at both doses, but only the low dose of infusion, which elicited a slow progressive response, causes an AT1R-dependent increase in intrarenal angiotensinogen expression.Keywords
This publication has 40 references indexed in Scilit:
- Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted miceAmerican Journal of Physiology-Renal Physiology, 2007
- Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient miceAmerican Journal of Physiology-Renal Physiology, 2007
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences of the United States of America, 2006
- Role of Extracellular Superoxide Dismutase in the Mouse Angiotensin Slow Pressor ResponseHypertension, 2006
- Enhancement of Collecting Duct Renin in Angiotensin II–Dependent Hypertensive RatsHypertension, 2004
- Essential Role of AT 1A Receptor in the Development of 2K1C HypertensionHypertension, 2002
- Ang II Accumulation in Rat Renal Endosomes During Ang II-Induced HypertensionHypertension, 2002
- Angiotensin-Converting Enzyme and Genetic Hypertension: Cloning of Rat cDNAs and Characterization of the EnzymeBiochemical and Biophysical Research Communications, 1994
- Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats.Hypertension, 1992
- Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system.Hypertension, 1992